IP Library Granted Patent US 9,074,243
Granted Patent B2
US 9,074,243 · App. 13/829,932 · Granted Jul 7, 2015

Detection of amplification products

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,074,243
App. No.
13/829,932
Granted
Jul 7, 2015
Kind
B2
Abstract

Compositions and methods are provided for quantitative detection of amplification products, the methods being suitable for multiplexing. A first oligonucleotide that includes a primer sequence for priming an amplification reaction and also is labeled with a fluorescent label or quencher is mixed with a second oligonucleotide which has a sequence suitable for hybridizing to a portion of the first oligonucleotide and has a fluorescent label if the first oligonucleotide has a quencher or a quencher if the first oligonucleotide has a fluorescent label; and a third nucleotide which includes some or all the primer sequence contained in the first oligonucleotide but is not labeled, the first and third oligonucleotide being combined in a molar ratio of 2.8 to 8.2.

Claims (11)

1. A composition, comprising:

in a buffer,

(a) a first oligonucleotide for priming an amplification reaction, the first oligonucleotide comprising: i. a primer sequence that is complementary to a site in a target sequence, a tail sequence that is not complementary to the target sequence and that is 5′ of the primer sequence, and iii. a quencher or fluorescent label;

(b) a second oligonucleotide having a sequence that is hybridized to the tail sequence of the first oligonucleotide to form a duplex, the second oligonucleotide having a fluorescent label if the first oligonucleotide has a quencher label, or having a quencher label if the first oligonucleotide has a fluorescent label;

(c) a third oligonucleotide comprising some or all of the primer sequence contained in the first oligonucleotide and not including a quenching or fluorescent label, wherein the third oligonucleotide is capable of hybridizing with the site in the target sequence and with the second oligonucleotide; and

(d) a strand displacing polymerase.

2. A composition according to claim 1 , wherein the second oligonucleotide is at a concentration that is substantially the same as the first oligonucleotide.

3. A composition according to claim 1 , wherein the first oligonucleotide has a quencher label and the second oligonucleotide has a fluorescent label or the first oligonucleotide has a fluorescent label and the second oligonucleotide has a quencher label.

4. A composition according to claim 1 , wherein a molar ratio of the first oligonucleotide to the third oligonucleotide is in the range of 2:8 to 8:2.

5. A composition according to claim 1 , wherein the strand-displacing polymerases is Bst DNA polymerase, large fragment.

6. The composition according to claim 1 , wherein the first oligonucleotide and the third oligonucleotide are combined in at least 1:1 molar ratio.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2023
From: TANNER, NATHAN; ZHANG, YINHUA; EVANS, THOMAS C.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 064561/0423 →